Atopic Dermatitis

https://doi.org/10.1016/j.yapd.2007.03.013Get rights and content

Section snippets

Epidemiology

Atopic dermatitis affects 10% to 20% of children and 1% to 3% of adults in the United States and Europe [9], [10]. The prevalence is higher in developed countries and urban areas and in populations that move from an area of low to high prevalence. Atopic dermatitis is more prevalent in temperate compared with tropical climates, especially dry winter climates [11]. The condition is also more prevalent in children who belong to families with a smaller size, higher socioeconomic class, and who

Pathogenesis and etiology

The pathogenesis of atopic dermatitis involves complex interactions between susceptible genes, immunologic factors, defects in the skin barrier, skin infection, and environmental factors [1].

There is a strong genetic predisposition. Approximately 30% to 50% of children who have one affected parent and 50% to 80% who have two affected parents develop the disorder [15]. The risk is higher with a family history of maternal compared with paternal atopy [16], [17]. Atopic dermatitis has a high

Immunopathology

Clinically unaffected skin of patients who have atopic dermatitis shows mild epidermal hyperplasia and sparse perivascular infiltration of T-helper 2 cells in the dermis [2]. Acute skin lesions are characterized by intracellular and intercellular edema of the epidermis (spongiosis), which is a histologic hallmark of atopic dermatitis [56]. There is marked perivascular infiltration of T-helper 2 cells in the dermis. Eosinophils, neutrophils, and mast cells are rarely present [56]. Chronic atopic

Clinical manifestations

Approximately 60% of children who have atopic dermatitis manifest the disease during the first year of life, and an additional 30% do so before the age of 5 years [1], [57]. Intense pruritus and cutaneous reactivity are the hallmarks of atopic dermatitis [1]. Pruritus increases the susceptibility of the surrounding skin to react to minimal stimuli and to illicit an itch, a phenomenon known as allokinesis [56]. Pruritus is exacerbated by scratching, which causes release of substance P from

Diagnosis

The diagnosis of atopic dermatitis is clinical and based on the presence of typical features. Criteria to define atopic dermatitis were first established by Hanifin and Rajka (Table 1) [67]. Although these criteria are useful for epidemiologic and therapeutic studies, many of the features are not common in children [66], and the minor criteria have not been validated in several studies [66], [68], [69]. In 1994, the United Kingdom Working Party developed more practical criteria for the

Assessment of severity and pyschosocial impact

Several scoring systems have been developed for the assessment of disease severity in children who have atopic dermatitis. The SCORing of Atopic Dermatitis (SCORAD) system, Eczema Area and Severity Index (EASI) system, and the Nottingham Eczema Severity Score (NESS) system are user-friendly, reliable, and in popular use [50], [72]. These systems generate quantifiable data that are amenable to analysis [72].

The SCORAD score ranges from 0 to 103 and measures the extent and intensity of the skin

Differential diagnosis

The differential diagnosis includes seborrheic dermatitis, psoriasis, acrodermatitis enteropathica, scabies, immunodeficiency disorders, nummular eczema, and contact dermatitis [66], [97].

The lesion in seborrheic dermatitis is usually asymptomatic and consists of an accumulation of a greasy yellow scale. In contrast, the lesion in atopic dermatitis is pruritic, the scale is dry, and excoriations are frequent. The diaper area might be involved in seborrheic dermatitis, but is typically spared in

Complications

Bacterial infection, most commonly with S. aureus, is the main complication of atopic dermatitis [100]. Purulent oozing honey-colored crusts, folliculitis, and pyoderma suggest secondary infection with S. aureus (Fig. 6). The anterior nares are an important reservoir of S. aureus [101]. Eczema herpeticum (Kaposi varicelliform eruption), caused by herpes simplex virus, is a potentially dangerous complication [57]. Eczema vaccinatum, caused by variola virus, follows smallpox vaccination or

Diagnostic testing

The diagnosis is based on a careful history and a thorough physical examination. Laboratory tests are usually not required. The need for further diagnostic work-up should be decided on an individual basis and should depend on the severity of the atopic dermatitis and the suspected factors involved [55], [109]. Hypereosinophilia in patients who have atopic dermatitis is a nonspecific finding and is also seen in patients who have asthma, allergic rhinitis, parasitic infestation, Hodgkin disease,

Management

Successful treatment requires a comprehensive approach that includes education of patients and caregivers, avoidance of triggering factors, optimal skin care, and pharmacotherapy.

Prognosis

Atopic dermatitis is characterized by exacerbations and remissions. Ten-year clearance rates vary from 40% to 80% for atopic dermatitis that begins in childhood [126]. Poor prognostic factors include early age at onset, severe disease, family history of atopic dermatitis, and concomitant asthma or allergic rhinitis [36], [192].

Summary

Atopic dermatitis is an especially common and frustrating condition, and the prevalence is increasing. The disease can adversely affect the quality of life of patients and caregivers. Significant advances in our understanding of the pathogenesis have led to improvements in therapy. Patient and caregiver education, avoidance of potential triggering factors, optimal skin care, and pharmacotherapy offer the potential for good control for most patients.

First page preview

First page preview
Click to open first page preview

References (192)

  • G. Imokawa

    Lipid abnormalities in atopic dermatitis

    J Am Acad Dermatol

    (2001)
  • P.G. Sator et al.

    Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis

    J Am Acad Dermatol

    (2003)
  • S.H. Cho et al.

    Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin

    J Allergy Clin Immunol

    (2001)
  • B. Wedi et al.

    Staphylococcal exotoxins exert proinflammatory effects through inhibition of eosinophil apoptosis, increased surface antigen expression (CD11b, CD45, CD54, and CD69), and enhanced cytokine-activated oxidative burst, thereby triggering allergic inflammatory reactions

    J Allergy Clin Immunol

    (2002)
  • R. Bunikowski et al.

    Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis

    J Allergy Clin Immunol

    (1999)
  • M.F. Hofer et al.

    Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen

    J Invest Dermatol

    (1999)
  • P.J. Hauk et al.

    Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens

    J Allergy Clin Immunol

    (2000)
  • D. Nissen et al.

    IgE–sensitization to cellular and culture filtrates of fungal extracts in patients with atopic dermatitis

    Ann Allergy Asthma Immunol

    (1998)
  • R.M. Levy et al.

    The epidemiology of atopic dermatitis

    Clin Dermatol

    (2003)
  • S. Watanabe et al.

    Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects

    J Allergy Clin Immunol

    (2003)
  • A.K.C. Leung

    Food allergy: a clinical approach

    Adv Pediatr

    (1998)
  • A.W. Burks et al.

    Atopic dermatitis: clinical relevance of food hypersensitivity reactions

    J Pediatr

    (1988)
  • R.A. Tupker et al.

    Induction of atopic dermatitis by inhalation of house dust mite

    J Allergy Clin Immunol

    (1996)
  • G. Schmid-Ott et al.

    Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison with healthy controls

    J Allergy Clin Immunol

    (2001)
  • C.A. Akdis et al.

    Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

    J Allergy Clin Immunol

    (2006)
  • D. Rudikoff et al.

    Atopic dermatitis

    Lancet

    (1998)
  • L. Kristal et al.

    Atopic dermatitis in infants and children

    Pediatr Clin North Am

    (2000)
  • J.M. Hanifin

    Atopic dermatitis

    J Am Acad Dermatol

    (1982)
  • L.F. Eichenfield et al.

    Consensus conference on pediatric AD

    J Am Acad Dermatol

    (2003)
  • K. Benjamin et al.

    The development of an objective method for measuring scratch in children with atopic dermatitis suitable for clinical use

    J Am Acad Dermatol

    (2004)
  • T.F. Leung et al.

    Plasma concentration of thymus and activation-regulated chemokine is elevated in childhood asthma

    J Allergy Clin Immunol

    (2002)
  • S.L. Chamlin et al.

    Development of the childhood atopic dermatitis impact scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families

    J Invest Dermatol

    (2005)
  • L. Drake et al.

    The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis

    J Am Acad Dermatol

    (2001)
  • A.K.C. Leung et al.

    Managing childhood atopic dermatitis

    Adv Ther

    (2003)
  • D.Y.M. Leung et al.

    New insights into atopic dermatitis

    J Clin Invest

    (2004)
  • M. Grillo et al.

    Pediatric atopic eczema: the impact of an educational intervention

    Pediatr Dermatol

    (2006)
  • M. Boguniewicz

    Update on atopic dermatitis: insights into pathogenesis and new treatment paradigms

    Allergy Asthma Proc

    (2004)
  • M.A. Dohil et al.

    A treatment approach for atopic dermatitis

    Pediatr Ann

    (2005)
  • K.L.E. Hon et al.

    CQLQ1, SCORAD and NESS: are they correlated?

    Qual Life Res

    (2006)
  • S. Foroughi et al.

    Advances in pediatric asthma and atopic dermatitis

    Curr Opin Pediatr

    (2005)
  • W. Kuster et al.

    A family study of atopic dermatitis. Clinical and genetic characteristics of 188 patients and 2,151 family members

    Arch Dermatol Res

    (1990)
  • T.C. Roos et al.

    Recent advances in treatment strategies for atopic dermatitis

    Drugs

    (2004)
  • F. Schultz Larsen

    Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample

    J Am Acad Dermatol

    (1993)
  • A. Haagerup et al.

    Atopic dermatitis—a total genome-scan for susceptibility genes

    Acta Derm Venereol (Stockh)

    (2004)
  • V.S. Beltrani et al.

    Atopic dermatitis

    Dermatol Online J

    (2003)
  • P.Y. Ong et al.

    Endogenous antimicrobial peptides and skin infections in atopic dermatitis

    N Engl J Med

    (2002)
  • M. Boguniewicz et al.

    Current management of atopic dermatitis and interruption of the atopic march

    J Allergy Clin Immunol

    (2003)
  • B.S. Baker

    The role of microorganisms in atopic dermatitis

    Clin Exp Immunol

    (2006)
  • M.W. Wessels et al.

    IgE antibodies to Pityrosporon ovale in atopic dermatitis

    Br J Dermatol

    (1991)
  • E. Buentke et al.

    Dendritic cells and fungi

    APMIS

    (2003)
  • Cited by (117)

    • Heavy metals in contact dermatitis: A review

      2023, Journal of Trace Elements in Medicine and Biology
    • Curative Potency of Medicinal Plants in Management of Eczema: A Conservative Approach

      2022, Phytomedicine Plus
      Citation Excerpt :

      The course of progression of the atopic triad was dependent on the allergen exposure accompanied by the interplay of all the genetic variables (Spergel, 2010; Spergel and Paller, 2003). Various therapeutic paradigms available for eczema included the use of emollients, topical and systemic corticosteroids, antimicrobials and immunomodulating agents(Leung et al., 2007). Corticosteroids being the prime choice have potent actions like terminating cytokine production, expression of adhesion molecule and leukocyte chemo taxis.

    • Skin Barrier Repair

      2022, Atopic Dermatitis: Inside Out or Outside In
    View all citing articles on Scopus
    View full text